Dr. med. D. M. Levy

Learn More
Immunocytochemistry for the general neuronal marker protein gene product 9.5 and four neuropeptides (calcitonin gene-related peptide, substance P, vasoactive intestinal polypeptide and neuropeptide Y) was performed on 20 skin biopsy specimens from 19 diabetic patients, age range 20–75 years, 17 Type 2 (non-insulin-dependent) and 3 Type 1(More)
Vasoactive intestinal polypeptide (VIP) and substance P (SP) immunoreactivity are reduced in the cutaneous nerves of diabetic patients with peripheral neuropathy. The functional significance of this finding was studied by measuring the forearm sweat response to intradermal methacholine and the effect of coadministration of VIP and SP in six normal subjects,(More)
Image-analysis was used to measure nerves immunoreactive to the general neuronal marker protein gene product 9.5 (PGP 9.5-IR) and the neuropeptides calcitonin gene-related peptide and vasoactive intestinal polypeptide in standardised leg skin biopsies of three age-matched groups of young subjects: non-diabetic (n=14), diabetic patients with normal small(More)
Peripheral small-fibre denervation has been reported to result in decreased activation of eccrine sweat glands to muscarinic cholinergic agents. Using computerised image-analysis of pilocarpine-activated sweatspot prints of a 4 cm2 area of the dorsum of the foot in 79 randomly selected diabetic patients we have identified a group of neuropathic patients(More)
1. Long-acting somatostatin analogue 201-995 safely reduces late night insulinopenic lipolysis in diabetic teenagers R. S. R. Aarsen 1., G.J. Bruining 1, W.F.A. Grose 2, N.C. den Boer 2, R.van Strik 3 and S.W.J.Lamberts 4. t Departments of Pediatrics, z Clinical Chemistry, 3 Biostatistics and 4 Internal Medicine, Erasmus University/Academic Hospital(More)
  • 1